Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations
LUND, SWEDEN – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world’s first blood-based test dedicated to the early detection of pancreatic cancer, today announced the appointment of Karl Stone as Chief Operating Officer effective 1 March, 2023. As anticipated when the new management structure was announced in October 2022, Immunovia has now added a new Chief Operating Officer role to its executive team to align with strategic priorities and focus on the US commercialization of the IMMray™ PanCan-d test. The Chief Operating Officer will be